Morenstein Scott D 4
4 · Molecular Templates, Inc. · Filed Nov 25, 2019
Insider Transaction Report
Form 4
Morenstein Scott D
Director
Transactions
- Purchase
Common Stock
2019-11-21$8.00/sh+468,750$3,750,000→ 2,052,991 total(indirect: See Footnote)
Footnotes (2)
- [F1]These shares are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (iii) Scott Morenstein, a Managing Director of the investment manager of CDK Associates, LLC.
- [F2]Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.